Ex vivo generation of clinical relevant amounts of human natural killer cells from CD34+haematopoietic progenitor cells for immunotherapy against acute myeloid leukaemia

被引：0
|
作者：
Spanholtz, J. [1 ]
Tordoir, M. [1 ]
Groenewegen, D. [2 ]
de Witte, T. [1 ]
Dolstra, H. [1 ]
机构：
[1] UMCN, Nijmegen, Netherlands
[2] Glycostem Therapeut, Nijmegen, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [21] Ex Vivo Generation of Highly Purified and Activated Natural Killer Cells from Human Peripheral Blood
    Saito, Satoru
    Harada, Yui
    Morodomi, Yosuke
    Onimaru, Mitsuho
    Yoshida, Kumi
    Kyuragi, Ryoichi
    Matsubara, Hisahiro
    Yonemitsu, Yoshikazu
    HUMAN GENE THERAPY METHODS, 2013, 24 (04) : 241 - 252
  • [22] Ex vivo generation of CD34+ cells from lineage- CD34- hematopoietic cells.
    Nakamura, Y
    Ando, K
    Sato, T
    Sumita, M
    Terashima, S
    Yoshida, M
    Yamashita, Y
    Chargui, J
    Kawada, H
    Tsuji, T
    Hotta, T
    Kato, S
    BLOOD, 1999, 94 (10) : 463A - 463A
  • [23] Ex vivo myeloid differentiation of CD34+progenitor cells from fresh or cryopreserved cord blood samples.
    De Bruyn, C
    Delforge, A
    Bron, D
    BLOOD, 2000, 96 (11) : 321B - 321B
  • [24] Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells
    Hägglund, HG
    McSweeney, PA
    Mathioudakis, G
    Bruno, B
    Georges, GE
    Gass, MJ
    Moore, P
    Sale, GE
    Storb, R
    Nash, RA
    TRANSPLANTATION, 2000, 70 (10) : 1437 - 1442
  • [25] Large-scale ex vivo generation of dendritic/myelomonocytic progenitor cells from CD34+-derived hematopoietic progenitor cells in the absence of human growth factors.
    Davis, TA
    Wannberg, SL
    Tuse, D
    BLOOD, 2001, 98 (11) : 278A - 278A
  • [26] Role of interleukin-15 in the development of human CD56(+) natural killer cells from CD34(+) hematopoietic progenitor cells
    Mrozek, E
    Anderson, P
    Caligiuri, MA
    BLOOD, 1996, 87 (07) : 2632 - 2640
  • [27] Ex vivo proliferation and differentiation of CD34+cells into myeloid progenitor cells: Cord blood versus mobilized peripheral blood
    De Bruyn, C.
    Delforge, A.
    Martiat, P.
    Bron, D.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 257 - 257
  • [28] Research report -: Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging
    Stilz, R
    Grünebach, F
    Bader, P
    Vogel, W
    Kanz, L
    Brugger, W
    Scheding, S
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (06): : 777 - 785
  • [29] Characterization and ex vivo expansion of human placenta-derived natural killer cells for cancer immunotherapy
    Kang, Lin
    Voskinarian-Berse, Vanessa
    Law, Eric
    Reddin, Tiffany
    Bhatia, Mohit
    Hariri, Alexandra
    Ning, Yuhong
    Dong, David
    Maguire, Timothy
    Yarmush, Martin
    Hofgartner, Wolfgang
    Abbot, Stewart
    Zhang, Xiaokui
    Hariri, Robert
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [30] Killing of Quiescent and Cycling Chronic Myeloid Leukemia CD34+Cells by Autologous Ex-Vivo Expanded Natural Killer Cells Is Enhanced by Bortezomib Treatment
    Yong, Agnes S. M.
    Stephens, Nicole
    Keyvanfar, Keyvan
    Savani, Bipin N.
    Eniafe, Rhoda
    Berg, Maria
    Sloand, Elaine M.
    Childs, Richard
    Barrett, A. John
    BLOOD, 2010, 116 (21) : 1389 - 1390
12345